Follow Us
© 2026 Arizent. All rights reserved.
It’s time to be creative. Here’s practical guidance benefit advisers can share with their clients to help them better control medication expenditures.
Due to high prices, some employees cannot afford to pay for their of critical medication.
RA medicine accounted for nearly half of specialty drug spend last year, inducing the pharmacy benefit manager to introduce a personalized savings program that could save employers $500,000 a year.
RA medicine accounted for nearly half of specialty drug spend last year, inducing the pharmacy benefit manager to introduce a personalized savings program that could save employers $500,000 a year.
This deal has strategic and financial benefits for Albertsons and helps the grocer avoid a choppy IPO market, but also gets it deeper into the increasingly tough and competitive pharmacy business.
A plan that includes employee coaching and support teams, financial incentives and prescription management is key.
Strategic Benefit Advisors prescribes strategies to manage the single largest driver of rising healthcare cost trend.
Strategic Benefit Advisors prescribes strategies to manage the single largest driver of rising healthcare cost trend.
Pharmacies in Canada, Australia, the U.K. and more can supply Rx medicine for less than half of U.S. prices.
Pharmacies in Canada, Australia, the U.K. and more can supply Rx medicine for less than half of U.S. prices.
Trump’s pick to lead the HHS said he’s open to negotiating some drug prices for Medicare, while backing a largely dormant proposal to repeal and replace parts of the ACA.
Employers should ask themselves how they are handling the Cadillac tax, if there is financial mischief occurring with pharmacy rebates and if they should amend plan documentation.
A costly revamp is needed to make vision behind Aetna deal reality.
Jeff Bezos has eyed the pharmacy business for years without plunging in. The upside may be too big to ignore.
The U.S. drug industry’s main lobbying group said it filed a lawsuit challenging the constitutionality of a California law meant to make drug prices more transparent.
Marrying price transparency with strong clinical programs can ensure proper administration of medication based on an individual’s needs.
The company is working with advisers to bring genomic testing to the workplace to determine risk for certain conditions and effectiveness of prescription medicine.
In the face of specialty drug cost increases, drug chain has created a program to help its sickest customers.
In the face of specialty drug cost increases, drug chain has created a program to help its sickest customers.
Move adds to drug chain’s string of deals in pharma, health and analytics.
